Although BOTs are not entirely recognized as malignant tumors and are not seen as a necessary process of transformation into ovarian cancer, in this study, we found some biomarkers related to EMTs, such as IL6, AKT1, MAPK3, SRC, TWIST1, and TGFB1 [59,60,61]. Here, TWIST1 is linked to ovarian cancer.